5,014 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Are Investors Undervaluing Norsk Hydro ASA (NHYDY) Right Now? https://www.zacks.com/stock/news/2238002/are-investors-undervaluing-norsk-hydro-asa-nhydy-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2238002 Mar 08, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
1 Wall Street Analyst Sees 69% Upside in Nio Stock. Is It a Buy Now? https://www.fool.com/investing/2024/03/07/1-wall-street-analyst-69-upside-nio-stock-buy/?source=iedfolrf0000001 Mar 07, 2024 - Nio expects its sales momentum and margins to pick up pace as 2024 progresses.
The 20 Best Movies on Apple TV+ Right Now https://www.wired.com/story/best-apple-tv-plus-movies/ Mar 07, 2024 - From Napoleon to Mad Max: Fury Road, here’s everything you should be watching on Apple’s streaming service.
Here's Why DocuSign (DOCU) Stock Is a Great Pick Right Now https://www.zacks.com/stock/news/2237573/here-s-why-docusign-docu-stock-is-a-great-pick-right-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2237573 Mar 07, 2024 - DocuSign (DOCU) focuses on product innovation, omnichannel go-to market, and financial and operational efficiency.
Cognizant (CTSH), Microsoft Team Up to Streamline Healthcare https://www.zacks.com/stock/news/2237560/cognizant-ctsh-microsoft-team-up-to-streamline-healthcare?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2237560 Mar 07, 2024 - Cognizant (CTSH) and Microsoft join forces to transform healthcare admin with generative AI integration on TriZetto.
Here's Why You Should Retain Walgreens Boots (WBA) For Now https://www.zacks.com/stock/news/2237551/here-s-why-you-should-retain-walgreens-boots-wba-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2237551 Mar 07, 2024 - Investors are optimistic about Walgreens Boots (WBA), led by its strategic partnerships and long-term growth model.
III or IT: Which Is the Better Value Stock Right Now? https://www.zacks.com/stock/news/2237500/iii-or-it-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2237500 Mar 07, 2024 - III vs. IT: Which Stock Is the Better Value Option?
BAP or RY: Which Is the Better Value Stock Right Now? https://www.zacks.com/stock/news/2237503/bap-or-ry-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2237503 Mar 07, 2024 - BAP vs. RY: Which Stock Is the Better Value Option?
Reasons to Retain Inari Medical (NARI) in Your Portfolio Now https://www.zacks.com/stock/news/2237411/reasons-to-retain-inari-medical-nari-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2237411 Mar 07, 2024 - Inari Medical (NARI) continues to benefit from its commitment to understanding the venous system. However, its dependency on the adoption of products is a concern.
Here's Why You Should Retain Merit Medical (MMSI) Stock for Now https://www.zacks.com/stock/news/2237409/here-s-why-you-should-retain-merit-medical-mmsi-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2237409 Mar 07, 2024 - Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
<<<Page 351>